| COVID-19 |
1 |
1 |
| Pregnancy |
0 |
0.99 |
| Severe Acute Respiratory Syndrome |
0 |
0.7 |
| Acute Respiratory Distress Syndrome |
0 |
0.6 |
| Child |
0 |
0.97 |
| Neurodevelopmental Disorder |
0 |
0.98 |
| Pandemic |
0 |
0.27 |
| Birth |
0 |
0.11 |
| Grant |
0 |
0.11 |
| Hospital |
0 |
0.11 |
| Massachusetts |
0 |
0.11 |
| Revenue and Practice Management |
0 |
0.11 |
| Patient Safety |
0 |
0.09 |
| Autism |
0 |
0.08 |
| Adverse Effects |
0 |
0.05 |
| Europe |
0 |
0.05 |
| Genetics |
0 |
0.05 |
| Genomic Medicine |
0 |
0.05 |
| Insurance |
0 |
0.05 |
| Multiple Sclerosis |
0 |
0.05 |
| Polymerase Chain Reaction |
0 |
0.05 |
| Utah |
0 |
0.05 |
| Viral Infection |
0 |
0.05 |